Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Modal Pinjaman
Keuangan
Harga Saham
USD
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 17.81B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Modal Pinjaman
Perubahan
Tanggal
Agilent
USD 3.64B
594M
2026-06
Align Technology
USD 0
0
2024-12
Bio Techne
USD 200M
60M
2026-03
Bio-Rad Laboratories
USD 803M
100K
2026-06
Bruker
USD 1.81B
151.8M
2026-06
Celltrion
KRW 411.27B
998.23M
2026-03
Charles River Laboratories
USD 2.62B
43.15M
2026-06
Cspc Pharmaceutical
CNY 180.69M
21.94M
2025-12
Danaher
USD 25.15B
7.59B
2026-06
Dentsply International
USD 2B
10M
2026-06
Deva Holding AS
TRY 559.97M
44.39M
2023-09
Dianthus Therapeutics
USD 0
0
2024-12
Divis Laboratories Ltd
INR 50M
30M
2026-03
Edwards Lifesciences
USD 598.7M
1.3M
2026-06
Illumina
USD 1.49B
1000K
2026-06
Intuitive Surgical
USD 0
0
2025-03
IQVIA Holdings
USD 13.7B
284M
2026-06
Kangmei Pharma
CNY 68.57M
9.87M
2026-03
Knight Therapeutics
CAD 57.78M
26.92M
2025-12
Laboratorios Farma
EUR 80.5M
28.26M
2024-12
Laboratory Of America
USD 5.92B
23.3M
2026-06
Malin Corporation
EUR 0
0
2024-12
Medical Developments International
AUD 1.5M
167K
2025-12
Mesa Laboratories
USD 104.2M
104.3M
2024-09
Mettler Toledo International
USD 2.04B
116.92M
2026-06
Myriad Genetics
USD 120.7M
400K
2026-06
OraSure Technologies
USD 100K
17K
2025-12
Organigram Holdings
CAD 60.76M
1.77M
2026-03
Ovoca Bio
EUR 0
0
2021-06
Pacific Biosciences Of California
USD 645.38M
223K
2025-12
Pharma Mar
EUR 32.13M
1.04M
2026-06
Qiagen NV
USD 1.63B
19.45M
2026-06
Quest Diagnostics
USD 5.63B
477M
2026-06
Quidel
USD 2.54B
2.54B
2026-06
Repligen
USD 551.05M
4.46M
2026-06
Revvity
USD 2.63B
1.02M
2026-06
Sartorius
EUR 3.65B
311.1M
2026-06
Sino Biopharmaceutical
CNY 3.08B
1B
2025-06
Thermo Fisher Scientific
USD 39.18B
890M
2026-06
Tilray
USD 268.59M
3.82M
2025-09
Waters
USD 5.09B
129M
2026-06
Zealand Pharma A/S
307M
76.14M
2026-03
Zz Pientze Pharmaceu
CNY 172.8M
9.49M
2026-06
×